MCL1 and cancer: Presented with the fact that FL118 targets and bypasses multi-drug resistance mechanisms, we hypothesized that FL118 should effectively reduce drug-resistant cancer cells including cancer stem cells (CSC) because the antiapoptotic proteins survivin [56–69] and Mcl-1 [70, 71] are known to play important roles in CSC drug resistance and function.